AKT1 and neoplasm: Notably, Akt/NICD1+Ezh2 (A/N+E2) mice developed a large tumour load 4 weeks after plasmid injection, while Akt/NICD1/Vector (A/N+V) mice developed only a small number of small lesions in the liver (Figure 3I).